Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verder is a privately held Dutch industrial technology group that operates globally through businesses focused on pumping solutions, laboratory equipment, and industrial investments. Its health-related activities are concentrated in the Verder Scientific division, which supplies laboratory, analytical, particle characterization, and pharmaceutical testing equipment used by pharmaceutical and life science companies, research laboratories, universities, and manufacturing sites. The group is not a drug developer and does not appear to run a therapeutic pipeline; instead, it generates revenue from commercial instrumentation, pumps, and related services. Key scientific brands associated with Verder include ERWEKA for pharmaceutical testing as well as other laboratory-equipment businesses spanning sample preparation, elemental analysis, and particle characterization. Overall, Verder is best understood as a diversified industrial and life science tools company rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verder.